Both GLP-1 and exendin-4 are antidiabetic peptides useful for treating type 2 diabetes that bind to and activate GLP-1 receptor thereby facilitating glucose-induced insulin secretion. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.